Form 8-K - Current report:
SEC Accession No. 0001493152-25-005205
Filing Date
2025-02-06
Accepted
2025-02-06 16:30:52
Documents
15
Period of Report
2025-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 56108
2 ex10-1.htm EX-10.1 230198
3 ex10-2.htm EX-10.2 238494
  Complete submission text file 0001493152-25-005205.txt   805006

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE maia-20250201.xsd EX-101.SCH 3024
5 XBRL LABEL FILE maia-20250201_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE maia-20250201_pre.xml EX-101.PRE 22365
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3784
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 25597862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)